AVM
Arch Venture Management Portfolio holdings
AUM
$299M
1-Year Return
19.47%
This Quarter Return
+22.16%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$104M
AUM Growth
+$3.52M
(+3.5%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-17.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Fate Therapeutics
FATE
|
+$14.1M |
| 2 |
Kura Oncology
KURA
|
+$4.15M |
Sector Composition
| 1 | Healthcare | 99.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
| $47.4M | 45.77% |
2,618,351
| – | – |
|
|
2
Kura Oncology
KURA
$711M
| $26.6M | 25.74% |
1,606,307
-250,000
| -13% | -$4.15M |
|
|
3
Fate Therapeutics
FATE
$111M
| $22.4M | 21.6% |
1,273,190
-800,000
| -39% | -$14.1M |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $6.22M | 6.01% |
1,196,776
| – | – |
|
|
BLPH
5
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $631K | 0.61% |
64,377
| – | – |
|
|
AKAO
6
DELISTED
Achaogen, Inc.
AKAO
| $285K | 0.28% |
624,544
| – | – |
|